PRLR drug-target Mendelian randomization for endometriosis

software OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-08-20 ⓘ

This drug-target Mendelian randomization study found that genetically predicted higher prolactin receptor expression increases endometriosis risk, a finding supported by colocalization and replication across multiple cohorts.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-20 · read from full text ⓘ

This study employs cis-expression quantitative trait locus Mendelian randomization to investigate the causal relationship between prolactin receptor expression and endometriosis risk. The researchers utilized summary statistics from large-scale genome-wide association studies, including data from eQTLGen, FinnGen, and the Rahmioglu 2023 endometriosis GWAS, alongside colocalization analyses to confirm shared genetic signals. The findings provide genetic evidence supporting the repurposing of prolactin receptor inhibition as a potential therapeutic strategy for treating endometriosis. This paper is centrally about endometriosis — specifically evaluating the genetic causality of the prolactin receptor pathway in disease pathogenesis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This repository contains the complete analysis code, data, figures, andsubmission-ready manuscript for a drug-target Mendelian randomization (MR)study of the prolactin receptor (PRLR) and endometriosis risk. Study summary:Using cis-eQTL instruments for PRLR from eQTLGen (primary instrumentrs6451196), we performed drug-target MR for endometriosis across FinnGenreleases (R8-R13), with replication in UK Biobank, the Sakaue 2021cross-population meta-analysis, the Rahmioglu 2023 European meta-analysis(GCST90205183), and BioBank Japan. Findings were validated by colocalisation(PP.H4=90.6%), SMR+HEIDI, and GTEx tissue eQTL analyses. Genetically predictedhigher PRLR expression was associated with increased endometriosis risk(FinnGen R13: beta=0.227, 95% CI 0.136-0.317, P=7.1e-7; OR=1.26). Contents:- scripts/: analysis scripts (Python/R) for MR, colocalisation, SMR+HEIDI, sensitivity, and figure generation- results/: analysis outputs and summary tables- manuscript/: submission-ready manuscript- manuscript_ebiomedicine_reformatted_fixed.md/.docx: final main text- supplementary_reformatted_fixed.md/.docx: supplementary materials- figures_final/: main figures (Figure 1-5) in editable PDF and 300-dpi PNG- supplementary_figS1-S3: supplementary figures All analyses used publicly available summary-level data. Please cite theassociated manuscript upon publication.
Full text 650 characters · extracted from oa-html · click to expand
This repository contains the analysis code and figures for: "Repurposing Prolactin Receptor Inhibition for Endometriosis: Genetic Evidence from cis-eQTL Mendelian Randomization and Colocalisation" scripts/ — Analysis scripts (MR, colocalisation, Steiger test, cross-population validation)figures/ — All 6 main figures (PDF and PNG)manuscript/ — Manuscript formatted for eBioMedicine submission All summary statistics used are publicly available: - eQTLGen: IEU OpenGWAS (https://gwas.mrcieu.ac.uk) - FinnGen R9/R10/R13: Google Cloud Storage - Rahmioglu 2023 EMs GWAS: GWAS Catalog GCST90044085 - GTEx V8: GTEx Portal Huihui Li — [email protected]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-30T06:08:52.026869+00:00
License: CC0 · commercial use OK